Previous studies suggested that tumor-infiltrating CD8+ T cells may function as Tregs, an important factor contributing to ocular immune privilege, which is the result of anterior chamber-associated immune deviation (ACAID) when antigens are introduced into the anterior chamber. The gene discussed is CD8A; the disease is neoplasm.